Many oncologists suggest waiting at least 2-5 years after completing cancer treatment before considering substances with any theoretical oncological concerns
Its typically recommended for those with a Body Mass Index (BMI) of 30 kg/m or higher, which falls within the obesity range
Its searchable library includes calculators for widely researched compounds such as BPC-157, semaglutide, tirzepatide, CJC-1295 and NAD+ , alongside metabolic, recovery, cognitive, dermatology and longevity-related research references
#ClinicalPharmacy #DrugDrugInteraction #PatientSafety #Clopidogrel #Pharmacovigilance #MedicationSafety #DTC #HospitalPharmacy #PharmD #AntiplateletTherapy #HealthcareQuality To view or add a comment, sign in 3,099 followers
Intravenous (IV) Glutathione Marketed in aesthetic clinics, especially in Asia No scientific evidence supports its use for skin lightening Carries risk of renal damage, infections, and severe adverse effects The Philippine FDA has issued public warnings against IV glutathione for cosmetic use Who Should Consider Glutathione Supplements
